<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02171377</url>
  </required_header>
  <id_info>
    <org_study_id>2009/091/HP</org_study_id>
    <secondary_id>2009-A00665-52</secondary_id>
    <nct_id>NCT02171377</nct_id>
  </id_info>
  <brief_title>Quadricipital Electrical Stimulation in COPD Patients Rehabilitation</brief_title>
  <acronym>Reha-Res</acronym>
  <official_title>Quadricipital Electrical Stimulation in COPD Patients Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quadricipital electrical stimulation added to respiratory rehabilitation in COPD patients.

      Quadricipital electrical stimulation (ES) in chronic obstructive pulmonary disease (COPD)
      patients has been demonstrated to improve both dyspnea and physical status. The aim of our
      study is to demonstrate that ES added to respiratory rehabilitation program induces a greater
      improvement on exercise tolerance in such patients.

      Design : 160 patients with severe COPD will be randomly assigned to 2 groups : either
      rehabilitation program (group 1), either ES and rehabilitation program (group 2). In both
      groups, rehabilitation program comprises endurance training, 18 - 24 sessions (6 - 8 weeks),
      health education, global muscular strengthening. In group 2, bilateral quadricipital
      electrical stimulation 30 min sessions is added 5 days / week.

      Subjects : COPD patients with FEV1 &lt; 60% pred, FEV1/VC &lt; 70%, and TLC &gt; 80%, with dyspnea, in
      stable conditions, and 18 &gt; BMI &lt; 35 kg/m² .

      Intervention : 6 min walking distance, incremental exercise test data (aerobic capacity, work
      rate, ventilatory threshold), physical activity with activity monitor, health related quality
      of life will be determined before and after training.

      Abbreviations : FEV1 = forced expiratory volume in 1 sec; VC = vital capacity; TLC = total
      lung capacity; BMI = body mass index.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 minute walking distance</measure>
    <time_frame>From 6 to 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incremental cardio pulmonary exercise test</measure>
    <time_frame>From 6 to 8 weeks</time_frame>
    <description>Aerobic capacity, maximal achieved work rate, ventilatory threshold</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Group 2 : quadricipital electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>stimulation in addition to rehabilitation (30 min bilateral quadricipital electrical stimulation pd, 5 days per week, 8 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 1 : Pulmonary rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulmonary rehabilitation 3 to 5 times per week, 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>group 2 : quadricipital electrical stimulation</intervention_name>
    <description>bilateral quadricipital electrical stimulation 5 sessions a week, (6 - 8 weeks)</description>
    <arm_group_label>Group 2 : quadricipital electrical stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pulmonary rehabilitation</intervention_name>
    <description>exercise training, 3 to 5 times per week, 8 weeks</description>
    <arm_group_label>Group 1 : Pulmonary rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>muscular electrical stimulation</intervention_name>
    <description>Bilateral quadricipital electrical stimulation 30 min, 5 times per week, 8 weeks,in addition to pulmonary rehabilitation</description>
    <arm_group_label>Group 2 : quadricipital electrical stimulation</arm_group_label>
    <other_name>Mi-Theta-Pro device (Compex medical SA ; CH - 1024 Ecublens); reference 498000 ; serial number WB100000.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pulmonary rehabilitation</intervention_name>
    <description>exercise training, 45 min, 3 to 5 times per week, 8 weeks</description>
    <arm_group_label>Group 1 : Pulmonary rehabilitation</arm_group_label>
    <other_name>exercise training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects : COPD patients with FEV1 &lt; 60% pred, FEV1/VC &lt; 70%, and TLC &gt; 80%, with
             dyspnea, in stable conditions, and 18 &gt; BMI &lt; 35 kg/m²

        Exclusion Criteria:

          -  BMI 18 &lt; or &gt; 35 kg/m²

          -  Pregnant women

          -  peripheral neuropathy

          -  cardio respiratory incremental test contra-indication

          -  evolutive cancer

          -  cardiac or cerebral pace maker, implanted cardio defibrillator

          -  no informed consent given
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2010</study_first_submitted>
  <study_first_submitted_qc>June 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2014</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>electrical stimulation</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>exercise test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

